FindTrial
Sign In

Dutch Multiple sclerosis study (DMSS)

A prospective, web-based, patient-centered, interactive study of long-term disabilities, disability perception and health-related quality of life in patients with multiple sclerosis (MS) and clinically isolated syndrome in the Netherlands.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22564
Enrollment
500
Registered
2021-05-27
Start date
2011-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis

Interventions

Care as usual

Sponsors

Nationaal MS Fonds Industrieweg 130C 3044 AT Rotterdam 010 – 591 98 39 info@nationaalmsfonds.nl Curavista bv Markt 9 4931 BR Geertruidenberg Tel: 0162 520 964 info@curavista.nl MS4 Research Institute Dr. Peter Joseph (Sjef) Jongen Ubbergseweg 34 6522 KJ Nijmegen The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Diagnosis of MS or Clinically Isolated Syndrome (CIS) 2) Willing and able to comply with the study protocol 3) Having access to the internet 4) Have given informed consent

Exclusion criteria

Exclusion criteria: Not defined

Design outcomes

Primary

MeasureTime frame
The primary study outcomes are disabilities (MSIP-Disability) and disability perceptions (MSIP-Disability perception)—

Secondary

MeasureTime frame
Disabilities as reported by an MS-specialized nurse (EDSS), health-related quality of life (MSQoL-54), and disease-modifying treatment utilization and persistence are the secondary outcomes of the study. Due to miscommunication, the two outcome measures; the Modified Fatigue Impact Scale-5 items (MFIS-5) and the Leeds Multiple Sclerosis Quality of Life (LMSQoL) reported in the initial study protocol were not included in the current study.—

Contacts

Public ContactGhislaine van Mastrigt

Maastricht University

g.vanmastrigt@maastrichtuniversity.nl0638615631

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)